Tiago M. Ribeiro de Oliveira , António J. Carmelo Romão , Pedro M. Simões de Oliveira , Sandro R. Silva Gaspar , Francisco M. Gamito Guerreiro , Tomé M. Matos Lopes
{"title":"Oxigenoterapia hiperbárica na cistite rádica hemorrágica","authors":"Tiago M. Ribeiro de Oliveira , António J. Carmelo Romão , Pedro M. Simões de Oliveira , Sandro R. Silva Gaspar , Francisco M. Gamito Guerreiro , Tomé M. Matos Lopes","doi":"10.1016/j.acup.2016.02.001","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>Due to considerable morbidity and mortality rates, radiation‐induced hemorrhagic cystitis is an important complication of pelvic irradiation. The available conservative treatment techniques show limited results. Hyperbaric oxygen has shown to be effective in the treatment of radiation‐induced lesions, including radiation cystitis. Our aim was to analyze the effectiveness and safety of hyperbaric oxygen therapy for refractory radiation‐induced hemorrhagic cystitis.</p></div><div><h3>Materials and Methods</h3><p>Clinical records of 176 patients with refractory radiation‐induced hemorrhagic cystitis treated at our centre were retrospectively analyzed. The evolution of macroscopic hematuria was the main therapeutic outcome analyzed.</p></div><div><h3>Results</h3><p>23,9% of patients showed other radiation‐induced soft tissue lesions. After an average of 37 sessions of hyperbaric oxygen, 89,8% of patients showed resolution of hematuria. Adverse events were reported in 1,7% of patients.</p></div><div><h3>Conclusions</h3><p>Hyperbaric oxygen was a safe and effective therapy for radiation‐induced hemorrhagic cystitis. Concomitant radiation‐induced soft tissue lesions were relatively frequent, which makes hyperbaric oxygen an excellent choice as first line treatment in those patients.</p></div>","PeriodicalId":100020,"journal":{"name":"Acta Urológica Portuguesa","volume":"33 1","pages":"Pages 1-5"},"PeriodicalIF":0.0000,"publicationDate":"2016-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.acup.2016.02.001","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Urológica Portuguesa","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2341402216000057","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Oxigenoterapia hiperbárica na cistite rádica hemorrágica
Objective
Due to considerable morbidity and mortality rates, radiation‐induced hemorrhagic cystitis is an important complication of pelvic irradiation. The available conservative treatment techniques show limited results. Hyperbaric oxygen has shown to be effective in the treatment of radiation‐induced lesions, including radiation cystitis. Our aim was to analyze the effectiveness and safety of hyperbaric oxygen therapy for refractory radiation‐induced hemorrhagic cystitis.
Materials and Methods
Clinical records of 176 patients with refractory radiation‐induced hemorrhagic cystitis treated at our centre were retrospectively analyzed. The evolution of macroscopic hematuria was the main therapeutic outcome analyzed.
Results
23,9% of patients showed other radiation‐induced soft tissue lesions. After an average of 37 sessions of hyperbaric oxygen, 89,8% of patients showed resolution of hematuria. Adverse events were reported in 1,7% of patients.
Conclusions
Hyperbaric oxygen was a safe and effective therapy for radiation‐induced hemorrhagic cystitis. Concomitant radiation‐induced soft tissue lesions were relatively frequent, which makes hyperbaric oxygen an excellent choice as first line treatment in those patients.